Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Prosperity Bancshares
PB
$8.74B
| $37.4M | 0.02% |
662,057
-111,383
| -14% | -$6.65M |
|
|
CMA
927
DELISTED
Comerica
CMA
| $37.3M | 0.02% |
881,271
-412,137
| -32% | -$16.7M |
|
928
BioCryst Pharmaceuticals
BCRX
$2.47B
| $37.3M | 0.02% |
5,302,020
+864,691
| +19% | +$6.94M |
|
929
Hilton Grand Vacations
HGV
$3.53B
| $37.2M | 0.02% |
818,783
+634,306
| +344% | +$28.3M |
|
|
DOCU
930
DocuSign
DOCU
$11.9B
| $37.2M | 0.02% |
727,994
+478,231
| +191% | +$25.3M |
|
931
Boot Barn
BOOT
$4.9B
| $37.2M | 0.02% |
439,035
+84,617
| +24% | +$6.21M |
|
932
PUT
Darden Restaurants
DRI
$25.6B
| $37.2M | 0.02% |
222,500
+155,400
| +232% | +$24.4M |
|
933
PUT
Rockwell Automation
ROK
$47.7B
| $37.2M | 0.02% |
112,800
+60,000
| +114% | +$17.3M |
|
934
PUT
CVS Health
CVS
$120B
| $37.2M | 0.02% |
537,500
-131,500
| -20% | -$9.36M |
|
935
PUT
Constellation Brands
STZ
$23.5B
| $37.1M | 0.02% |
150,900
+78,300
| +108% | +$18.3M |
|
936
PUT
iShares China Large-Cap ETF
FXI
$4.24B
| $37.1M | 0.02% |
1,365,000
+1,050,000
| +333% | +$29.5M |
|
937
Agilent Technologies
A
$43.3B
| $37M | 0.02% |
308,029
-622,969
| -67% | -$79.4M |
|
|
CD
938
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $37M | 0.02% |
5,169,799
+3,127,895
| +153% | +$20M |
|
939
Gates Industrial Corp
GTES
$6.59B
| $37M | 0.02% |
2,745,514
+1,350,938
| +97% | +$17.5M |
|
|
GMS
940
DELISTED
GMS Inc
GMS
| $36.9M | 0.02% |
532,942
+504,679
| +1,786% | +$31.2M |
|
|
941
PUT
Linde
LIN
$226B
| $36.9M | 0.02% |
96,700
+20,800
| +27% | +$7.6M |
|
942
PUT
Take-Two Interactive
TTWO
$43.7B
| $36.8M | 0.02% |
250,200
+219,800
| +723% | +$28.7M |
|
943
Tapestry
TPR
$26.4B
| $36.6M | 0.02% |
855,244
-27,971
| -3% | -$1.16M |
|
944
Dover
DOV
$27.4B
| $36.6M | 0.02% |
247,810
+224,172
| +948% | +$32M |
|
945
Cirrus Logic
CRUS
$5.6B
| $36.4M | 0.02% |
449,121
+384,166
| +591% | +$31.8M |
|
946
PUT
Quanta Services
PWR
$92.7B
| $36.3M | 0.02% |
185,000
+84,000
| +83% | +$14.7M |
|
947
Allegiant Air
ALGT
$2.23B
| $36.3M | 0.02% |
287,614
+271,458
| +1,680% | +$28.4M |
|
948
CALL
Mondelez International
MDLZ
$82.6B
| $36.2M | 0.02% |
496,900
+71,000
| +17% | +$5.25M |
|
949
Navitas Semiconductor
NVTS
$3.19B
| $36.2M | 0.02% |
3,435,560
+2,187,034
| +175% | +$16.9M |
|
950
Acuity Brands
AYI
$10.1B
| $36.2M | 0.02% |
221,989
+137,479
| +163% | +$22M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.